Curia Invests $4 Million to Enhance Sterile API Manufacturing
Curia has completed a $4 million upgrade to its sterile API manufacturing suites in Valladolid, Spain, to enhance product quality, safety, and regulatory compliance.
Pharma
Hovione Completes $100 Million Investment to Expand Operations at US Manufacturing Site
Hovione has completed a $100 million investment to double spray-drying capacity and expand its East Windsor, New Jersey site, positioning the facility to meet growing US demand.
SK Pharmteco Invests $6.1 Million in Peptide Manufacturing at California Facility
SK Pharmteco has announced a $6.1 million investment to expand its Rancho Cordova, California, facility with new lab and kilo-scale capabilities for solid-phase peptide synthesis and purification.
Orion and Abzena Announce Exclusive Antibody Commercial License
Abzena, an end-to-end integrated CDMO for complex biologics and bioconjugates, announced that Orion has obtained an exclusive focused commercial license to one of Abzena’s mAbs..
A Balanced Model for the Future of Life Sciences
Following the acquisition of MCE Pharma Brenntag is building a unique position in both traditional pharma and biopharma.
Sharp Services Invests $100 Million in US and European Facilities
Investments will bolster clinical and commercial capacity in US and Europe facilities for injectable and oral solid dose packaging, and sterile filling.
Cambrex Invests $120 Million to Expand US API Manufacturing
Cambrex announced a $120 million investment to expand its API manufacturing capacity at its Charles City, Iowa, facility by 40%.
ACG Invests $200 Million in US Hard-Shell Capsule Manufacturing
The investment will focus on developing gelatin and HPMC facilities, creating over 200 new jobs, and strengthening ACG’s 25-year presence in the US, with operations expected to begin in early 2027.
17.10.2025 • News
Roquette Opens Pharmaceutical Innovation Center in Brazil
Roquette has inaugurated a new Pharmaceutical Innovation Center in Brazil to support advanced research and development in the region’s pharmaceutical sector.
Pharma 4.0—the Key Enabler for Successful Digital Transformation in Pharma
Part 3: Seven Theses for successful Digitalization in Pharma
09.10.2025 • News
Harke Pharma Acquires Groundbreaking Memory Complex
Harke Pharma has completed the acquisition of a highly acclaimed nutraceutical Memory Complex originally developed by Green Bioactives, UK.
Pharma 4.0 — the Key Enabler for Successful Digital Transformation in Pharma
Part 2: Digital transformation - 10 Years after the Start of Pharma 4.0
Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma
Part 1: Building a Business Case for Pharma 4.0
01.10.2025 • News
Symeres Appoints Gabriella Gentile as Chief Operating Officer
Symeres has appointed Gabriella Gentile as Chief Operating Officer to lead global operations and drive transatlantic growth, leveraging her extensive experience in the pharmaceutical and biotech sectors.
30.09.2025 • News
AbbVie Breaks Ground on US API Manufacturing Facility
New state-of-the-art active pharmaceutical ingredient (API) facility in North Chicago will manufacture immunology, oncology, and neuroscience medicines.
Pharma Strategies for Stability
October 15, 2025 | Join us for a dynamic virtual event where science meets strategy.
29.09.2025 • News • Bioprocessing
Siegfried Opens cGMP Viral Vectors Manufacturing Facility
Dinamiqs, a Siegfried company specialized in viral vector design and manufacturing, inaugurated its new cGMP manufacturing facility.
Lilly to Build $6.5 Billion US Pharmaceutical Plant
Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Houston, Texas.
Pfizer Agrees to Take Over Metsera for $4.9 Billion
Pfizer to acquire Metsera, a New York, NY-based clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases.
Prange Pharma Acquires Site in Italy from MSD
Prange Pharma is taking over a production site from MSD Animal Health in Aprilia, Italy. A new center for contract manufacturing in the field of animal health products is to be established there.
Roche to Acquire 89Bio in $3.5 Billion Deal
Acquisition supports Roche’s strategy as it enhances the company’s portfolio in cardiovascular, renal, and metabolic diseases (CVRM) and offers optionality for future combination development.
GSK to Invest $30 Billion in US R&D and Manufacturing
Includes $1.2 billion in manufacturing facilities, AI, and advanced digital technologies, creating hundreds of highly skilled US jobs.
Performance Improvement in Pharmaceuticals Operations
The pharmaceutical industry has faced significant margin pressures due to rising energy costs, inflation, and geopolitical disruptions.
Stability in Motion
Amid global uncertainty, Bayer Pharma, led by Stefan Oelrich, pursues strategic transformation to boost resilience, drive innovation, and secure sustainable growth in a changing healthcare landscape.
• 17.09.2025 • News • Bioprocessing
Strategic Perspectives on Life Sciences Industry Transformation
Asahi Kasei Life Science emerges as a new growth driver, uniting bioprocess solutions, CRO, and CDMO services to shape the future of healthcare under President Ken Shinomiya’s leadership.
LGC Opens $100 Million Pharma Synthesis Center in Canada
LGC Group has inaugurated a CAD$100 million (€61.5 million) Organic Chemistry Synthesis Centre of Excellence in Vaughan, Canada.
11.09.2025 • News
Novo Nordisk to Cut 9,000 Jobs Globally in Major Restructuring
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
Smart Capacity Planning for Pharma & Biotech Company
How pharma & biotech company transformed warehouse capacity planning for strategic growth
10.09.2025 • News
Symeres Acquires DGr Pharma
CRDMO Symeres has acquired DGr Pharma, expanding its capabilities with DGr Pharma’s regulatory and consultancy expertise to provide more comprehensive drug development services.
Gilead Breaks Ground on New US Manufacturing Hub
New Bay Area building marks significant progress as part of Gilead's $32 billion US investment.
Genentech and Roche Break Ground on US Manufacturing Facility
The $700 million project is part of Genentech and Roche’s $50 billion investment in U.S. manufacturing, infrastructure and R&D
AbbVie to Acquire Gilgamesh Pharmaceutical’s Psychedelic Drug for $1.2B
Gilgamesh's lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD).
AstraZeneca to Invest $50 Billion in US Manufacturing
AstraZeneca recently announced $50 billion of investment in the US by 2030. This investment is expected to create tens of thousands of new, highly skilled jobs nationwide.
Pharma Service Provider Vetter Establishes New Site in Chicago
Vetter broke ground for the start of construction of its new clinical site in Des Plaines, Illinois, US on June 26.
IMCD Acquires Indian Pharma Supplier Trichem
IMCD, a global partner for the distribution and formulation of speciality chemicals and ingredients, has acquired Trichem, an Indian pharmaceutical supplier.
Ontario Int. Marketing Ct.
Aenova Holding GmbH
KPMG AG Wirtschaftsprüfungsges.
Avantor
GETEC Group
Managm. Consult. Chemicals
Merck KGaA
WeylChem International GmbH
Helsinn Chemicals SA
Blue Sphere Health Ltd.
Lilly Deutschland GmbH
AstraZeneca
VCI Verband Chem.- Ind. e.V
EvaluatePharma
Accenture
Scienceindustries - Wirtschaftsverband Chemie Pharma Life Sciences
LGC Group
Arthur D. Little
AbbVie Inc.
Asahi Kasei Europe
Ashland
Groupe Novasep
Datamonitor Group
Sanofi S.A.
Symeres
Mack Brooks Exhibition Ltd – Part of RX
SchüllerConsulting
gempex GmbH – THE GMP-EXPERT
RX Trace
Pfizer, Inc.
Siegfried
Roche Group
Sharp Services
Thomson Reuters
GBI Research
LISA Life Science Austria
Gilead Sciences, Inc.
Packaging Coordinators, Inc.
Cambrex Corporation
CHEManager International c/o Wiley-VCH GmbH
Farmindustria
Datamonitor Group
Roquette
GlaxoSmithKline (GSK) plc
Novo Nordisk A/S
A.T. Kearney GmbH
Evonik Nutrition & Care GmbH (Hanau)
PureTech Systems
F. Hoffmann-La Roche Ltd
Brenntag SE